Indolo[2,3-a]carbazole Derivatives with Antitumor Activity and Instrumental Methods for Their Investigation (Review)
Introduction. Currently, more than 600 thousand people a year are affected by malignant tumors on the territory of the Russian Federation. Despite the large selection of antitumor drugs and the variety of mechanisms of their action, the effectiveness of existing drugs continues to be insufficient. T...
Main Authors: | D. A. Kozin, Z. S. Shprakh, V. Yu. Reshetnyak, O. V. Nesterova, I. N. Avertseva, G. M. Rodionova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2020-11-01
|
Series: | Разработка и регистрация лекарственных средств |
Subjects: | |
Online Access: | https://www.pharmjournal.ru/jour/article/view/836 |
Similar Items
-
Standardization of the Pharmaceutical Substance of the Drug LCS-1208
by: E. V. Ignateva, et al.
Published: (2021-08-01) -
STANDARDIZATION OF INCLUSION COMPLEX OF DISULFIRAM WITH HYDROXYPROPYL-β-CYCLODEXTRIN FOR USE AS PHARMACEUTICAL SUBSTANCES
by: S. A. Kedik, et al.
Published: (2019-01-01) -
Preparation of 2-phenyl-9-diethylaminoethylimidazo[1,2-α]benzimidazole dinitrate tablets and development of quality control methods
by: A. M. Domanina, et al.
Published: (2021-05-01) -
ACTIVE SUBSTANCES FOR DOMESTIC MANUFACTURER OF MEDICINES: PAST, PRESENT AND FUTURE
by: K. O. Sidorov, et al.
Published: (2019-01-01) -
Pharmaceutical Industry Development in the Midst of Crisis: Global Trends
by: Z. A. Mamedyarov
Published: (2020-12-01)